Neuroregulation technology empowers precision medicine—Jiutou Bird Medical successfully concludes its participation in the Asia-Pacific Congress on Sexual and Reproductive Medicine.

On April 13, 2025, the highly anticipated "Asia-Pacific Congress on Sexual and Reproductive Medicine and the 20th Academic Conference of the Asia-Pacific Society for Sexual Medicine (APSSM)—the 18th National Congress on Sexual Medicine" successfully concluded in Nanjing. As an innovation leader in urology and andrology neuroregulation technology, Jiutouniao Medical Group showcased its cutting-edge solutions—integrating optoelectromagnetic approaches into a multi-faceted treatment strategy—alongside several groundbreaking technologies and products. With its exceptional scientific expertise and premium services, the company earned widespread acclaim from experts, scholars, and industry peers both domestically and internationally, injecting a powerful "innovation boost" into the conference.

During the meeting, the Chairman of Jiutouniao Medical Group engaged in an in-depth discussion with President Jiang Hui of the Asia-Pacific Society of Sexual Medicine and President Dai Yutian of the Sexual Medicine Branch of the Chinese Medical Association, followed by a commemorative photo session. This encounter underscores Jiutouniao Medical's pivotal role in fostering collaborative development between academia and industry, laying a solid foundation for future international partnerships.

At the Nine-Headed Bird Medical booth, the highly acclaimed male sexual function biofeedback device, along with the male sexual rehabilitation therapy unit and the home-use "Little Apple" series, are redefining the new standard for functional disorder recovery—thanks to their dual-core technology combining "neuroregulation + magnetic stimulation therapy." Among these innovations, the male sexual function biofeedback diagnostic system integrates penile erection hardness assessment, Doppler ultrasound, sensitivity threshold testing, and neuroelectrophysiological analysis into a single, comprehensive tool. This system is recognized as the "gold standard" for diagnosing premature ejaculation. Moreover, pathological examinations not only determine the nature of the condition but also provide critical insights into how the disease develops over time, offering clinicians more robust evidence to guide treatment. For clients struggling with male health issues, we offer tailored consultation, physiotherapy, and feedback solutions, while also maintaining confidential patient information records. This personalized approach ensures patients receive exclusive, high-quality care designed to support their journey toward recovery.

This exhibition not only showcases Jiutouniao Medical’s cutting-edge innovation capabilities but also marks a milestone in collaborating with global reproductive medicine leaders to drive shared growth. Jiutouniao Medical Group sincerely thanks the conference organizers, esteemed experts, and our valued partners for their trust and support. Moving forward, we will remain committed to our core mission of "Using technology to safeguard life," embracing industry changes with an even more open mindset while delivering tangible results that benefit medical professionals and patients worldwide. Together, let’s allow the light of innovation to illuminate hope for every life!